Sanibel Captiva Trust Company’s GSK GSK Stock Holding History

Sanibel Captiva Trust Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$565K	Sell	10,782 -27	-0.2%	-$1.43K	0.01%	313
2026 Q1	$597K	Sell	10,809 -1,657	-13%	-$89.8K	0.02%	286
2025 Q4	$611K	Buy	12,466 +461	+4%	+$21.5K	0.02%	273
2025 Q3	$518K	Sell	12,005 -520	-4%	-$20.3K	0.01%	289
2025 Q2	$481K	Sell	12,525 -211	-2%	-$8.06K	0.01%	285
2025 Q1	$493K	Sell	12,736 -1,897	-13%	-$69.4K	0.02%	273
2024 Q4	$495K	Sell	14,633 -1,718	-11%	-$61.8K	0.02%	277
2024 Q3	$668K	Sell	16,351 -380	-2%	-$15.5K	0.02%	249
2024 Q2	$644K	Hold	16,731	–	–	0.02%	245
2024 Q1	$717K	Buy	16,731 +90	+0.5%	+$3.71K	0.02%	226
2023 Q4	$617K	Buy	+16,641	New	+$597K	0.02%	221

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Sanibel Captiva Trust Company's GSK Position: Q2 2026 in Review

Sanibel Captiva Trust Company reduced its GSK (GSK) stake by 0.25% in Q2 2026, selling an estimated $1.43K and leaving 10,782 shares worth $565K. The position accounts for 0.01% of the portfolio, ranked #313.

Sanibel Captiva Trust Company first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. The position peaked at $717K in Q1 2024. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Sanibel Captiva Trust Company held 10,782 shares of GSK worth $565K as of Q2 2026.
Sanibel Captiva Trust Company sold 27 GSK shares in Q2 2026, an estimated $1.43K.
GSK made up 0.01% of Sanibel Captiva Trust Company's portfolio in Q2 2026, its #313 holding.
Sanibel Captiva Trust Company first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
Sanibel Captiva Trust Company's GSK position peaked at $717K in Q1 2024.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2026, filed 27 Jul 2026.